搜索筛选:
搜索耗时0.0738秒,为你在为你在102,285,761篇论文里面共找到 4 篇相符的论文内容
类      型:
[会议论文] 作者:Li-ping Hu,Yan Xu,Zeng-Jun Li,Shu-hui Deng,Mei-rong Zang,De-Hui Zhou,Gang An,Wei-ping Yuan,Tao Cheng,Lu-Gui Qiu, 来源:The 35th World Congress of the International Society of Hema 年份:2014
[会议论文] 作者:Li-ping Hu,Yan Xu,Zeng-Jun Li,Shu-hui Deng,Mei-rong Zang,De-Hui Zhou,Gang An,Wei-ping Yuan,Tao Cheng,Lu-Gui Qiu, 来源:The 35th World Congress of the International Society of Hema 年份:2014
Background The cytogenetic abnormalities are the most important prognostic factor and can be used to guide therapy decisions in multiple myeloma (MM).It has been currently recognized the negative impa...
[会议论文] 作者:Yuan-Kai Shi,Mei Dong,Zhi-Xiang Shen,Yun Fan,Wei Li,Xie-Lan Zhao,Lu-Gui Qiu,He Huang,Dao-bin Zhou,Xiao-Nan, 来源:22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份:2013
[会议论文] 作者:Yuan-Kai Shi,Zhi-Xiang Shen,Yun Fan,Wei Li,Xie-Lan Zhao,Lu-Gui Qiu,He Huang,Dao-bin Zhou,Mei Dong,Xiao-Nan, 来源:22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份:2013
Objective: To evaluate chidamide efficacy and safety in relapsed or refractory peripheral T-cell lymphoma (PTCL) in Chinese patients.Methods: Exactly 102 PTCL patients were enrolled.In the exploratory...
相关搜索: